# Jeremy Schmahmann, M.D. – FDA Inspection, Apr 15, 2025

Source: https://www.keypedia.com/records/fda_inspections/jeremy-schmahmann-md/ce28e394-29cf-4a1b-bed2-3268ceba93b3
Source feed: FDA_Inspections

> FDA inspection 1269424 of Jeremy Schmahmann, M.D., April 15, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269424
- Company Name: Jeremy Schmahmann, M.D.
- Inspection Date: 2025-04-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1324468 - 2026-06-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/jeremy-schmahmann-md/6289e135-bb69-4f47-88b6-7d365908c3a2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c